We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,563

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIL icon
13351
CALL
Instil Bio
TIL
$50.1M
$6.34K ﹤0.01%
575
-295
-34% -$3.61K
RVLP
13352
CALL
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$6.33K ﹤0.01%
11,300
-18,700
-62% -$16.5K
MFIN icon
13353
PUT
Medallion Financial
MFIN
$264M
$6.33K ﹤0.01%
800
-1,100
-58% -$7.54K
ELDN icon
13354
PUT
Eledon Pharmaceuticals
ELDN
$273M
$6.3K ﹤0.01%
4,600
+3,200
+229% +$6.67K
NEWP
13355
New Pacific Metals
NEWP
$1.27B
$6.29K ﹤0.01%
2,884
-19,813
-87% -$48.5K
FTRI icon
13356
PUT
First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF
FTRI
$130M
$6.29K ﹤0.01%
500
RFL icon
13357
CALL
Rafael Holdings
RFL
$103M
$6.27K ﹤0.01%
3,042
-11,458
-79% -$22.9K
VTEX icon
13358
PUT
VTEX
VTEX
$618M
$6.24K ﹤0.01%
1,300
-400
-24% -$1.59K
SVVC
13359
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$6.23K ﹤0.01%
9,893
-3,876
-28% -$3.27K
VHC icon
13360
CALL
VirnetX Holding Corp
VHC
$62.8M
$6.23K ﹤0.01%
670
-2,380
-78% -$29.2K
VHC icon
13361
PUT
VirnetX Holding Corp
VHC
$62.8M
$6.23K ﹤0.01%
670
-2,315
-78% -$28.4K
NGM
13362
CALL
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$6.22K ﹤0.01%
2,400
+2,100
+700% +$7.49K
ACIU icon
13363
PUT
AC Immune
ACIU
$253M
$6.21K ﹤0.01%
2,100
+1,400
+200% +$3.06K
RANI icon
13364
PUT
Rani Therapeutics
RANI
$89.5M
$6.18K ﹤0.01%
1,500
-2,600
-63% -$12.1K
ADN
13365
PUT
DELISTED
Advent Technologies
ADN
$6.18K ﹤0.01%
350
-253
-42% -$6.11K
BYSI icon
13366
BeyondSpring
BYSI
$34.5M
$6.17K ﹤0.01%
5,232
-4,239
-45% -$4.73K
UE icon
13367
CALL
Urban Edge Properties
UE
$2.76B
$6.17K ﹤0.01%
400
-1,000
-71% -$14.4K
NBSTW
13368
DELISTED
Newbury Street Acquisition Corporation Warrants
NBSTW
$6.17K ﹤0.01%
32,557
+21,621
+198% +$3.68K
AWRE icon
13369
CALL
Aware
AWRE
$26.4M
$6.16K ﹤0.01%
3,900
+700
+22% +$1.15K
NTWK icon
13370
CALL
NetSol Technologies
NTWK
$48.3M
$6.14K ﹤0.01%
2,600
+2,200
+550% +$5.17K
CURI icon
13371
CuriosityStream
CURI
$210M
$6.13K ﹤0.01%
6,578
-54,740
-89% -$54.6K
DHX icon
13372
CALL
DHI Group
DHX
$171M
$6.13K ﹤0.01%
1,600
+1,400
+700% +$5.19K
SMRT icon
13373
CALL
SmartRent
SMRT
$286M
$6.13K ﹤0.01%
1,600
-3,200
-67% -$9.78K
ASTR
13374
PUT
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$6.12K ﹤0.01%
1,107
-233
-17% -$1.33K
UAMY icon
13375
United States Antimony
UAMY
$825M
$6.09K ﹤0.01%
+19,341
New +$6.65K

Similar funds

Citadel Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Citadel Advisors held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Citadel Advisors withdrew a net $16.6B in Q2 2023, closing 1,563 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in BILL Holdings worth $222M.

  • Citadel Advisors's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Citadel Advisors added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Citadel Advisors's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Citadel Advisors fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Citadel Advisors's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Citadel Advisors opened 1,205 new positions and closed 1,563 in Q2 2023.
  • Citadel Advisors's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.